Lin et al.218 loaded iRGD-modified exosomes with siCPT1A to specifically deliver CPT1A siRNA to colon cancer cells, thus reversing oxaliplatin resistance by regulating fatty acid oxidation. This evidence concerns the gene CPT1A and malignant colon neoplasm.